Cannapūr® Technology
Competitive Advantages
At Fiberlab we believe in maintaining the integrity of the whole plant material with our proprietary “Zero Molecular Destruction™” technology delivering “Cannabinoids the way Nature Intended™.”
Proprietary IP
Fiberlab® proprietiary Cannapūr® technology, exclusively engineered by Katzen International, provides novel methodologies for Industrial Hemp biomass extraction and crude oil enrichment, purification and separation if desired, in a continous flow process for unmatched economies of scale and superior finished products. Our proprietary technology removes unwanted fatty acids, waxes, gums, and other impurities from crude oil leaving an enriched full spectrum oil (FSO) with <0.3% THC which may then be further refined into a variety of cannabinoid products including our T-Free™ (THC-Free) Broad Spectrum Oil (BSO). The Cannabinator®, which is the core component of our Cannapūr operating system, is a skid mounted all stainless steel plug-and-play system with a small, energy efficient footprint that requires very low maintenance and is ideally suited for long-term cost effective operations. Our closed-loop cryogenic extraction and cold filtered process uses no heat or pressure thereby maintaining the integrity of the whole natural plant material, delivering “cannabinoids the way nature intended“. The Cannabinator is scalable and is very flexible allowing for clean acid cannabinoid separation and extracted crude oil to be heated to its decarboxylation point if desired by the client. Sustainable continuous flow economies of scale producing diverse and superior finished product lines across multiple applications give Fiberlab a distinct competitive advantage to capture market share.
Compounding
The scientific experts at Fiberlab are able to maximize the efficiencies of our IP by fractionalizing, or separating out individual acid cannabinoids in a continous stream process. These bulk separated cannabinoids can then be compounded or blended together to achieve the optimal profile for treating a patient’s symptoms, medical diagnosis or scalable pharmaceutical prescriptions. Cannabinoids are infused to the precise dose prescribed by a Doctor or to a patients desired potency and effect. Currently there is no technology on the market capable of separating cannabinoids for compounding on the scale Fiberlab offers.
Research and Development
Fiberlab is continually developing novel methods for our Cannapūr technology to increase efficiencies and expand its product capabilities to further strengthen our position as the leading custom solutions provider of “Disruptive Technology for the Cannabinoid Industry™”.
